Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
-
Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences
-
Allogene Therapeutics to Report Fourth Quarter and Year-End 2022 Financial Results on February 28, 2023
-
Allogene Therapeutics to Report Fourth Quarter and Year-End 2022 Financial Results on February 28, 2023
-
Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences
-
Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences
-
Allogene Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
-
Allogene Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
-
Allogene Therapeutics To Host Research & Development Showcase and Participate in Five Upcoming Investor Conferences
-
Allogene Therapeutics To Host Research & Development Showcase and Participate in Five Upcoming Investor Conferences
-
Allogene Overland Biopharm Completes Buildout of cGMP Manufacturing Facility in Shanghai to Support the Development of AlloCAR T™ Products in Asia
-
Allogene Overland Biopharm Completes Buildout of cGMP Manufacturing Facility in Shanghai to Support the Development of AlloCAR T™ Products in Asia
-
Allogene Therapeutics Publishes Inaugural Environmental, Social and Governance (ESG) Report
-
Allogene Therapeutics Publishes Inaugural Environmental, Social and Governance (ESG) Report

